+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Skelaxin"

Skelaxin - API Insight, 2022 - Product Thumbnail Image

Skelaxin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Skelaxin- Drug Insight, 2019 - Product Thumbnail Image

Skelaxin- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Skelaxin (metaxalone) is a centrally-acting skeletal muscle relaxant used to treat muscle spasms and pain. It is a member of the class of drugs known as central nervous system (CNS) drugs, which are used to treat a variety of conditions, including muscle spasms, seizures, and anxiety. Skelaxin is typically prescribed for short-term relief of muscle spasms and pain, and is not intended for long-term use. It is available in both oral and injectable forms. Skelaxin is marketed by Pfizer, Inc., and is available in the United States, Canada, and other countries. It is also available as a generic drug, which is manufactured by several different companies. Some companies in the Skelaxin market include Pfizer, Inc., Mylan Pharmaceuticals, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more